211 related articles for article (PubMed ID: 18953428)
1. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.
Menschikowski M; Hagelgans A; Kostka H; Eisenhofer G; Siegert G
Neoplasia; 2008 Nov; 10(11):1195-203. PubMed ID: 18953428
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.
Menschikowski M; Hagelgans A; Gussakovsky E; Kostka H; Paley EL; Siegert G
Neoplasia; 2008 Mar; 10(3):279-86. PubMed ID: 18320072
[TBL] [Abstract][Full Text] [Related]
3. On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression.
Menschikowski M; Hagelgans A; Hempel U; Lattke P; Ismailov I; Siegert G
Thromb Res; 2008; 122(1):69-76. PubMed ID: 17936881
[TBL] [Abstract][Full Text] [Related]
4. Secreted phospholipases A₂are differentially expressed and epigenetically silenced in human breast cancer cells.
Brglez V; Pucer A; Pungerčar J; Lambeau G; Petan T
Biochem Biophys Res Commun; 2014 Feb; 445(1):230-5. PubMed ID: 24508801
[TBL] [Abstract][Full Text] [Related]
5. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic control of group V phospholipase A2 expression in human malignant cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Mareninova OA; Asatryan L; Siegert G
Tumour Biol; 2016 Jun; 37(6):8097-105. PubMed ID: 26715269
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of multiple secretory phospholipase A(2) isoforms in the rat CNS: enriched expression of sPLA(2)-IIA in brainstem and spinal cord.
Ma MT; Nevalainen TJ; Yeo JF; Ong WY
J Chem Neuroanat; 2010 Jul; 39(4):242-7. PubMed ID: 20153419
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.
Menschikowski M; Platzbecker U; Hagelgans A; Vogel M; Thiede C; Schönefeldt C; Lehnert R; Eisenhofer G; Siegert G
BMC Cancer; 2012 Dec; 12():576. PubMed ID: 23217014
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death.
Titsworth WL; Cheng X; Ke Y; Deng L; Burckardt KA; Pendleton C; Liu NK; Shao H; Cao QL; Xu XM
Glia; 2009 Nov; 57(14):1521-37. PubMed ID: 19306380
[TBL] [Abstract][Full Text] [Related]
12. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.
Antonio V; Brouillet A; Janvier B; Monne C; Bereziat G; Andreani M; Raymondjean M
Biochem J; 2002 Dec; 368(Pt 2):415-24. PubMed ID: 12188923
[TBL] [Abstract][Full Text] [Related]
14. Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.
Menschikowski M; Hagelgans A; Heyne B; Hempel U; Neumeister V; Goez P; Jaross W; Siegert G
Biochim Biophys Acta; 2005 Apr; 1733(2-3):157-71. PubMed ID: 15863363
[TBL] [Abstract][Full Text] [Related]
15. Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.
Sullivan CP; Seidl SE; Rich CB; Raymondjean M; Schreiber BM
J Biol Chem; 2010 Jan; 285(1):565-75. PubMed ID: 19850938
[TBL] [Abstract][Full Text] [Related]
16. Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.
Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):739-46. PubMed ID: 18196260
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.
Liu JH; Bian YM; Xie Y; Lu DP
Mol Med Rep; 2015 Jul; 12(1):1059-65. PubMed ID: 25815463
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of the circadian clock: role of 5-aza-2'-deoxycytidine.
Tomita T; Kurita R; Onishi Y
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487473
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of the JAK3/STAT1 pathway on the release of secreted phospholipase A₂-IIA in microvascular endothelial cells of the injured brain.
Wang G; Qian P; Xu Z; Zhang J; Wang Y; Cheng S; Cai W; Qian G; Wang C; Decoster MA
J Neuroinflammation; 2012 Jul; 9():170. PubMed ID: 22788969
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
